Seligmann, JF, Domingo, E, Fisher, D et al. (17 more authors) (2022) The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC). In: 2022 ASCO Annual Meeting, 03-07 Jun 2022, Chicago, Il, USA and Online.
Metadata
Item Type: | Conference or Workshop Item |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Funding Information: | Funder Grant number Cancer Research UK Supplier No: 138573 C7852/A19772 Leeds Teaching Hospitals Charitable Foundation Fund No IT01 Cancer Research UK Supplier No: 138573 RCS REF 08-0843 SUBCONTR Cancer Research UK Supplier No: 138573 C6003/A7367 Leeds Hospitals Charity 1T01-A321 Leeds Teaching Hospitals Charitable Foundation 4616 Cancer Research UK Supplier No: 138573 C6003/A15546 Amgen Limited ***USE 819922*** NOT GIVEN MRC (Medical Research Council) 2012-005111-12 NIHR National Inst Health Research 2012-005111-12 |
Depositing User: | Symplectic Publications |
Date Deposited: | 21 Nov 2022 13:57 |
Last Modified: | 21 Nov 2022 13:57 |
Status: | Published |
Identification Number: | 10.1200/JCO.2022.40.16_suppl.3540 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:193386 |
Download not available
A full text copy of this item is not currently available from White Rose Research Online